Actively Recruiting
Study of NK Cell Therapy Given Into the Brain and Through the Vein to Treat Malignant Solid Brain Tumors in Adults Aged 18 to 70
Led by Peking University Third Hospital · Updated on 2026-04-27
27
Participants Needed
4
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, tolerability, and feasibility of a combined natural killer NK cell therapy administered both inside the brain and through the bloodstream in adults with malignant solid brain tumors who have not responded to standard treatments. This trial aims primarily to find the highest safe dose of this combined NK cell therapy. Secondary goals include early assessments of its anti-tumor effects using measures like progression-free survival, overall survival, and tumor response, along with studying immune changes in the tumor and blood. Participants receive NK cell therapy through intracranial or intrathecal injections using a surgically implanted reservoir or lumbar puncture, combined with intravenous infusions. There are three dosing groups low, medium, and high dose, each receiving intracranial injections of 100 million NK cells every two weeks paired with increasing intravenous doses every two weeks. This open-label trial is randomized and conducted at multiple centers. During the study, participants will be closely monitored for adverse events and dose-limiting toxicities up to three months after treatment. Researchers will assess tumor response and duration of response at three months post-treatment. Participants must have regular MRI scans with contrast and laboratory tests to evaluate organ function and immune response. The total participation period includes treatment and follow-up assessments to evaluate safety and preliminary effectiveness of the therapy.
CONDITIONS
Brief Title
NK Cell Therapy for Malignant Solid Brain Tumors
Research Team
C
Chenlong YANG, M.D., Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here